CLDN18.2/PD-L1 dual-targeting CAR-T
/ Sichuan University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 19, 2024
Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=29 | Recruiting | Sponsor: Sichuan University | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor • CLDN18
October 16, 2023
Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients With CLDN18.2-positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=29 | Not yet recruiting | Sponsor: Sichuan University
Metastases • New P1 trial • Oncology • Solid Tumor • CLDN18
1 to 2
Of
2
Go to page
1